Cargando…
Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic
Autores principales: | Zhu, Jing, Rao, Gauri, Armistead, Paul M., Ptachcinski, Jonathan, Weiner, Daniel L., Wiltshire, Tim, Crona, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652756/ https://www.ncbi.nlm.nih.gov/pubmed/34743423 http://dx.doi.org/10.1111/cts.13177 |
Ejemplares similares
-
Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients
por: Zhu, Jing, et al.
Publicado: (2021) -
Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients
por: Zhu, Jing, et al.
Publicado: (2020) -
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era
por: Morello, Enrico, et al.
Publicado: (2018) -
Allogeneic stem cell transplantation for neuroblastoma
por: Sung, Ki Woong
Publicado: (2012) -
Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)